DHC Q2 SHOP NOI Jumps 37%, Reaffirms Raised 2026 Guidance
DHC has more than doubled off its 52-week low of $3.235.
Summary
DHC's Q2 2026 results show a 37.2% jump in same-property SHOP NOI, reaffirmed raised guidance, and a Moody's upgrade — the senior housing recovery is gaining traction.
Key Events · Earnings and Guidance · DHC
-
SHOP NOI Surges 37.2%
Comparable SHOP net operating income rose to $52.0M from $37.9M a year ago, driven by occupancy gains (83.1% vs. 81.5%) and a 6.2% increase in average monthly rate to $5,715.
-
Reaffirms Raised 2026 Guidance
Management reiterated the full-year 2026 guidance it raised on June 1, 2026, which increased Normalized FFO by $10M. Q2 Normalized FFO of $0.16/share covers the $0.01 quarterly distribution 16 times.
-
Interest Expense Drops 27%
Interest expense fell to $37.1M from $50.9M a year ago, reflecting the redemption of high-cost 9.75% notes and senior secured notes due 2026, partially offset by new 7.25% notes and mortgage debt.
-
Moody's Upgrades Credit Rating
Moody's upgraded DHC's issuer rating to B3 from Caa1 and assigned a positive outlook, citing improving operating performance and debt reduction.
Analysis · DHC · Real Estate & Construction
Diversified Healthcare Trust's Q2 results show a sharp turnaround in its senior housing operating portfolio (SHOP), with same-property net operating income surging 37.2% on higher occupancy and rates. The company reaffirmed its recently raised full-year 2026 guidance, signaling confidence the recovery is on track. Interest expense dropped 27% from a year ago after refinancing high-cost debt, and Moody's upgraded the credit rating to B3 with a positive outlook. The quarter had no asset impairments, unlike the $31 million charge a year earlier. The main blemish is a $37.4 million net loss, but that includes non-cash depreciation — normalized FFO was $0.16 per share, well above the $0.01 quarterly distribution.
At the time of this filing, DHC was trading at $8.89 on NASDAQ in the Real Estate & Construction sector, with a market capitalization of approximately $2.2B. The 52-week trading range was $3.24 to $9.66. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.